...
首页> 外文期刊>Journal of sex and marital therapy >Validation of the Change or Stop Testosterone-Lowering Medication (COSTLow) Scale Using the Delphi Method Among Clinical Experts
【24h】

Validation of the Change or Stop Testosterone-Lowering Medication (COSTLow) Scale Using the Delphi Method Among Clinical Experts

机译:使用临床专家中的Delphi方法验证改变或停止睾酮降低药物(Costlow)规模

获取原文
获取原文并翻译 | 示例
           

摘要

Guidelines for pharmacological treatment of patients with paraphilic disorders have been developed by a working group of the World Federation of Societies of Biological Psychiatry (Thibaut et al., 2010). With an increasing duration of experience and number of treated patients as well as aging patients, change of or withdrawal from testosterone-lowering medications (TLM) has become an important issue. The current study aimed to assess the quality of a structured professional judgment procedure that helps switching or discontinuing TLM in patients with paraphilic disorders. We used the Delphi method to estimate the quality of 10 factors originally proposed by the authors. A total of 30 experts participated in the first stage; 18 experts participated in the second stage. The experts’ assessment resulted in an instrument of 15 factors that can be used to structure the process of changing or discontinuing TLM. These factors can be grouped into five broader categories: age and duration of treatment; therapeutic alliance; psychopathology and risk factors; motivation; and compliance and level of control. The developed COSTLow-R Scale provides an instrument that can be used to structure the process of changing or discontinuing TLM in patients with severe paraphilic disorders. ? 2018, ? 2018 Taylor & Francis Group.
机译:世界各州的生物精神病学联合会(Thibaut等,2010)是制定了含糖性疾病患者的药理治疗指南(Thibaut等,2010)。随着持续时间的经验和治疗患者的数量以及老化患者,睾丸激素降低药物(TLM)的变化或戒断已成为一个重要问题。目前的研究旨在评估结构化的专业判断程序的质量,有助于在含糖障碍患者中切换或停止TLM。我们使用了Delphi方法来估计作者最初提出的10个因素的质量。共有30名专家参加了第一阶段; 18名专家参加了第二阶段。专家的评估导致了一个有15个因素的仪器,可用于构建改变或停止TLM的过程。这些因素可以分为五个更广泛的类别:年龄和治疗持续时间;治疗联盟;精神病理学和危险因素;动机;并遵守和控制水平。开发的COSTLOW-R级别提供了一种仪器,可用于构建严重致脂疾病患者的改变或停止TLM的过程。还2018年,? 2018泰勒&弗朗西斯集团。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号